The angiotensin II type 1 receptor antagonist (angio-tensin receptor blocker [ARB]) losartan has been shown in the LIFE (Losartan Intervention for Endpoint Reduction in Hypertension) study to ...

This study demonstrates that candesartan had greater efficacy in lowering arterial pressure when compared to losartan. Moreover, the duration of effect and response/control rates were ...